You are here : Home Healthcare Payment Link for Sterlitech Corporation - Track etched Membrane Market & Pharmaceutical Filtration Market Drug formulations ATC Antiinfectives for Systemic Use Vaccines Animal Vaccines

Global Conjugate vaccines Market Research Report

Conjugate vaccines and Live attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Recombinant vaccines, DNA vaccines, Sub-unit vaccines and Other Vaccine technology adds up to total Animal Vaccines market.

Conjugate vaccines can be segmented by Types, Geographies, MacroIndicators and Companies. Types of this market are Preventive and Therapeutic. Geographies of this market are North America, Europe, Asia, Rest of World and Other Geographies. MacroIndicators of this market are Healthcare Expenditure. Companies of this market are Pfizer Inc, Sanofi, Merck & Co., Inc., Virbac, Bayer Pharmaceuticals and Other Companies.

Key Questions Answered

What are market estimates and forecasts; which of Conjugate vaccines markets are doing well and which are not?
What is the competitive landscape; How companies like Pfizer Inc, Sanofi and Merck & Co., Inc. doing in Conjugate vaccines?

What makes our report unique?

This report provides market sizing and forecast for the Conjugate vaccines market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
The report provides deep dive competitive landscape covering the top players such as Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
The reports provides benchmarking insight on the top players Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
The report provide competitive intelligence on Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.

Audience for this report

Global Conjugate vaccines companies
Manufacturing Companies
Traders, distributors, and suppliers
Governmental and research organizations
Associations and industry bodies
Technology providers

	PRODUCT TITLE	PUBLISHED
	North American Conjugate vaccines Market The North American conjugate animal vaccine market is mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $64.3million in 2013 and is expected to reach $83.9 million by 2018 at a CAGR of 5.5% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.	Upcoming
	European Conjugate Vaccines Market The European conjugate animal vaccine market is mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $76.4 million in 2013 and is expected to reach $105.3 million by 2018 at a CAGR of 6.6%. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.	Upcoming
	Asian Conjugate Vaccines Market The Asian conjugate animal vaccine market is mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $34.2 million in 2013 and is expected to reach $62.6 million by 2018, at a CAGR of 12.8% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.	Upcoming

3 of 3 items

3 reports | Show

Connect With Us

US/CAN : +1-888-502-0539

sales@micromarketmonitor.com

Subscription

Animal Vaccines